Abstract
C16H15FN2O2, monoclinic, P21/c (no. 14), a = 14.6825(16) Å, b = 11.7155(11) Å, c = 8.8285(7) Å, β = 102.753(10)°, V = 1481.2(2) Å3, Z = 4, Rgt (F) = 0.0670 wRref (F 2) = 0.1669, T = 293 K.
The crystal structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Data collection and handling.
Crystal: | Block, colourless |
Size: | 0.42 × 0.37 × 0.32 mm |
Wavelength: | Mo Kα radiation (0.71073 Å) |
μ: | 0.09 mm−1 |
Diffractometer, scan mode: | Bruker SMART, φ and ω-scans |
θ max, completeness: | 29.3°, >99 % |
N(hkl)measured, N(hkl)unique, R int: | 6706, 3406, 0.023 |
Criterion for I obs, N(hkl)gt: | I obs > 2σ(I obs), 2188 |
N(param)refined: | 192 |
Programs: | Bruker programs [1], SHELX [2, 3], OLEX2 [4] |
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).
x | y | z | U iso*/U eq | |
---|---|---|---|---|
C1 | 0.4480 (2) | 0.9984 (3) | 0.2661 (4) | 0.0844 (10) |
C2 | 0.4618 (2) | 0.8848 (3) | 0.2691 (3) | 0.0780 (8) |
H2 | 0.504545 | 0.852190 | 0.218435 | 0.094* |
C3 | 0.41068 (17) | 0.8176 (2) | 0.3494 (3) | 0.0601 (6) |
H3 | 0.419211 | 0.738868 | 0.352947 | 0.072* |
C4 | 0.34696 (16) | 0.86685 (18) | 0.4244 (2) | 0.0461 (5) |
C5 | 0.33580 (19) | 0.9843 (2) | 0.4208 (3) | 0.0620 (7) |
H5 | 0.294012 | 1.018274 | 0.472369 | 0.074* |
C6 | 0.3871 (2) | 1.0511 (2) | 0.3401 (3) | 0.0829 (10) |
H6 | 0.380245 | 1.130049 | 0.336522 | 0.099* |
C7 | 0.28993 (16) | 0.79810 (18) | 0.5108 (2) | 0.0445 (5) |
C8 | 0.18331 (15) | 0.52828 (18) | 0.4896 (2) | 0.0439 (5) |
C9 | 0.12743 (15) | 0.47227 (18) | 0.5878 (2) | 0.0432 (5) |
C10 | 0.09510 (18) | 0.3603 (2) | 0.5589 (3) | 0.0595 (7) |
H10 | 0.111027 | 0.319859 | 0.477888 | 0.071* |
C11 | 0.0404 (2) | 0.3081 (2) | 0.6470 (3) | 0.0687 (7) |
H11 | 0.019206 | 0.233901 | 0.624211 | 0.082* |
C12 | 0.01716 (19) | 0.3657 (2) | 0.7682 (3) | 0.0674 (7) |
H12 | −0.020125 | 0.330813 | 0.827265 | 0.081* |
C13 | 0.04885 (18) | 0.4745 (2) | 0.8022 (3) | 0.0610 (7) |
H13 | 0.034069 | 0.512496 | 0.886060 | 0.073* |
C14 | 0.10263 (15) | 0.52878 (19) | 0.7134 (2) | 0.0460 (5) |
C15 | 0.20053 (19) | 0.4696 (2) | 0.3468 (3) | 0.0615 (7) |
H15A | 0.148311 | 0.419619 | 0.305276 | 0.074* |
H15B | 0.203935 | 0.526534 | 0.268487 | 0.074* |
C16 | 0.2884 (3) | 0.4013 (4) | 0.3793 (5) | 0.1219 (14) |
H16A | 0.294377 | 0.361643 | 0.286823 | 0.183* |
H16B | 0.286624 | 0.347045 | 0.460038 | 0.183* |
H16C | 0.340895 | 0.451337 | 0.411932 | 0.183* |
F1 | 0.49699 (16) | 1.0654 (2) | 0.1871 (3) | 0.1378 (9) |
N1 | 0.26706 (12) | 0.69130 (14) | 0.45606 (18) | 0.0430 (4) |
H1 | 0.284732 | 0.664779 | 0.376361 | 0.052* |
N2 | 0.21402 (12) | 0.62795 (14) | 0.53535 (18) | 0.0418 (4) |
O1 | 0.26594 (12) | 0.83618 (13) | 0.62555 (16) | 0.0597 (5) |
O2 | 0.12761 (12) | 0.63765 (13) | 0.75253 (18) | 0.0563 (5) |
H2A | 0.159798 | 0.662198 | 0.694776 | 0.085* |
1 Source of materials
In the experimental procedure, 1 mmol of 4–fluorobenzohydrazide and 1 mmol of 2′-hydroxypropiophenone were added to a 50 mL round-bottom flask containing 25 mL of absolute alcohol and 5 drops of glacial acetic acid. The resulting solution was stirred at 60 °C for 1 h. The mixture was then stirred for an additional 5 h before the solvent was evaporated to a dry state using a rotary evaporator. The crude product was dissolved in a minimal amount of hot ethanol and then slowly cooled to room temperature, resulting in a single crystal.
2 Experimental details
The data were integrated and scaled using the program SAINT [1], and the structure was solved using SHELXT [2]. The final refinement was performed using SHELXL [3] within the Olex2 software package [4]. The hydrogen atoms were placed in calculated positions and refined isotropically using the riding model.
3 Comment
One of the significant research aspects of the N-acylhydrazone moiety is its ability to exhibit diverse pharmacological activities, including anti-inflammatory, anticonvulsant, antiviral, and anticancer properties [5]. Another crucial application of the N-acylhydrazone moiety is its potential as a versatile scaffold for the synthesis of novel small-molecule therapeutics. The determination of single crystal structure for the N-acylhydrazone moiety is significant for understanding their different conformations and orientations that ultimately affect their biological activities [6], [7], [8].
The title molecule adopts an E configuration, which resulted in a long C=N double bond length. As shown in the figure, the bond length of C8=N2 is 1.284(3) Å and the bond length of C7–N1 is 1.357(3) Å. The dihedral angle between the benzene ring and the plane of the hydrazide group is about 15.9°. The bond distances in the crystal structure are standard, and the angles are close to ideal values [9], [10], [11], [12], [13], [14].
The compound also exhibits an intramolecular hydrogen bonding interaction (O2–H2A⃛N2). The bond length is 1.8085(19) Å, and the bond angle is 145.01(12)°. The 2-hydroxyphenyl group and the hydrazide group are in the same plane, and the dihedral angle between these two plane is about 5.7°, which is due to the hydrogen bonding interactions.
Single crystal structure analysis provides a detailed understanding of the molecular arrangement of this compound in a crystal’s lattice, including bond lengths, bond angles, and dihedral angles, similar to reported structures [15], [16], [17], [18], [19].
-
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
-
Research funding: This work was financially supported by the projects of key research and development project of Shaanxi Provincial Science and Technology Department (2022SF-448), Scientific research plan project of Shaanxi Provincial Department of Education (22JK0276) and the Xianyang key laboratory of molecular imaging and drug synthesis (2021QXNL–PT-0008).
-
Conflict of interest statement: The authors declare no conflicts of interest regarding this article.
References
1. Bruker. APEX2, SAINT and SADABS; Bruker AXS Inc.: Madison, WI, USA, 2012.Search in Google Scholar
2. Sheldrick, G. M. SHELXT–Integrated space-group and crystal-structure determination. Acta Crystallogr. 2015, A71, 3–8; https://doi.org/10.1107/s2053273314026370.Search in Google Scholar PubMed PubMed Central
3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Search in Google Scholar
4. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A., Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Search in Google Scholar
5. Thota, S., Rodrigues, D. A., Pinheiro, P. D. S. M., Lima, L. M., Fraga, C. A. M., Barreiro, E. J. N–Acylhydrazones as drugs. Bioorg. Med. Chem. Lett. 2018, 28, 2797–2806; https://doi.org/10.1016/j.bmcl.2018.07.015.Search in Google Scholar PubMed
6. Xue, L.-W., Han, Y.-J., Zhao, G.-Q., Feng, Y.-X. Synthesis, characterization and crystal structures of N′-(5–Bromo-2-hydroxybenzylidene)-2-fluorobenzohydrazide in unsolvated and monohydrate forms. J. Chem. Crystallogr. 2011, 41, 1599–1603; https://doi.org/10.1007/s10870-011-0146-z.Search in Google Scholar
7. Ajayeoba, T. A., Woods, J. O., Ayeni, A. O., Ajayi, T. J., Akeem, R. A., Hosten, E. C., Akinyele, O. F. Synthesis, crystallographic, computational and molecular docking studies of new acetophenone-benzoylhydrazones. J. Mol. Struct. 2021, 1237, 130275; https://doi.org/10.1016/j.molstruc.2021.130275.Search in Google Scholar
8. Liu, B., Liu, H., Zhang, H., Di, Q., Zhang, H. Crystal engineering of a hydrazone molecule toward high elasticity and bright luminescence. J. Phys. Chem. Lett. 2020, 11, 9178–9183; https://doi.org/10.1021/acs.jpclett.0c02623.Search in Google Scholar PubMed
9. Bai, Z.-C., Li, H., Liu, Y., Jing, Z.-L. N′-(2,4–Dichlorobenzylidene)-2-methoxybenzohydrazide. Acta Crystallogr. E 2006, 62, o2295–o2296; https://doi.org/10.1107/s1600536806017053.Search in Google Scholar
10. Fun, H.-K., Horkaew, J., Chantrapromma, S. (E)-4–Hydroxy-N′-(3-hydroxy-4-methoxybenzylidene) benzohydrazide. Acta Crystallogr. E 2011, 67, o2644–o2645; https://doi.org/10.1107/s1600536811036579.Search in Google Scholar PubMed PubMed Central
11. Yang, J.-G., Pan, F.-Y. 2′-(2–Fluorobenzylidene)-2-hydroxybenzohydrazide. Acta Crystallogr. E 2004, 60, o2009–o2010; https://doi.org/10.1107/s1600536804024614.Search in Google Scholar
12. Hao, Y.-M. Crystal structure of 2-chloro-N′-(2-methoxybenzylidene) benzohydrazide, C15H13ClN2O2. Z. Kristallogr. N. Cryst. Struct. 2011, 226, 11–12; https://doi.org/10.1524/ncrs.2011.0006.Search in Google Scholar
13. Hao, Y.-M. Crystal structure of 3-chloro–N′-(2-hydroxy-3,5-diiodobenzylidene)-benzohydrazide methanol solvate, C14H9ClI2N2O2.CH3OH. Z. Kristallogr. N. Cryst. Struct. 2011, 226, 13–14; https://doi.org/10.1524/ncrs.2011.0007.Search in Google Scholar
14. Hao, Y.-M. Crystal structure of 2-chloro-N′-(2-hydroxy-3,5-dichlorobenzylidene)-benzohydrazide-methanol (1:1), C14H9Cl3N2O2.CH3OH. Z. Kristallogr. N. Cryst. Struct. 2011, 226, 47–48; https://doi.org/10.1524/ncrs.2011.0023.Search in Google Scholar
15. Bai, B., Zhang, M., Ji, N., Wei, J., Wang, H., Li, M. E–Z isomerization of the –C=N– bond in anthracene-based acylhydrazone derivatives under visible light. Chem. Commun. 2017, 53, 2693–2696; https://doi.org/10.1039/c6cc08403f.Search in Google Scholar PubMed
16. Peng, S.-J. Synthesis, crystal structures, and antibacterial activity of two hydrazone derivatives 3-methoxy-N′-(3,5-dibromo-2-hydroxybenzylidene) benzohydrazide methanol solvate and 3-methoxy-N′-(2,4-diclorobenzylidene) benzohydrazide. J. Chem. Crystallogr. 2011, 41, 280–285; https://doi.org/10.1007/s10870-010-9873-9.Search in Google Scholar
17. Zhu, H.-Y. Synthesis, characterization, and crystal structures of 3-bromo-N′-(2-methoxybenzylidene)benzohydrazide and N′-(2-methoxybenzylidene)-3,4-methylenedioxybenzohydrazide. J. Chem. Crystallogr. 2011, 41, 1785–1789; https://doi.org/10.1007/s10870-011-9982-0.Search in Google Scholar
18. Zhu, M.-A., Qiu, X.-Y. Synthesis and crystal structures of N′-(5–Bromo-2-hydroxy-3-methoxybenzylidene)-4-methoxybenzohydrazide and 4-{[1-(5-bromo-2-hydroxy3-methoxyphenyl)methylidene] amino}-1-methyl-2-phenyl-1,2-dihydropyrazol-3-one. J. Chem. Crystallogr. 2011, 41, 69–72; https://doi.org/10.1007/s10870-010-9839-y.Search in Google Scholar
19. Ferraresi-Curotto, V., Echeverría, G. A., Piro, O. E., Pis-Diez, R., González-Baró, A. C. Structural, spectroscopic and DFT study of 4-methoxybenzohydrazide Schiff bases. A new series of polyfunctional ligands. Spectrochim. Acta Part A 2015, 137, 692–700; https://doi.org/10.1016/j.saa.2014.08.095.Search in Google Scholar PubMed
© 2023 the author(s), published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution 4.0 International License.
Articles in the same Issue
- Frontmatter
- New Crystal Structures
- Crystal structure of a polymorph of potassium picrate, C6H2KN3O7
- The crystal structure of (1E,2E)-1,2-bis(quinolin-2-ylmethylene)hydrazine, C20H14N4
- 5-Amino-2-chloro-4-fluoro-N-(N-isopropyl-N-methylsulfamoyl) benzamide, C11H15O3ClFN3S
- Crystal structure of trans-N 1,N 8-bis(2-cyanoethyl)-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane, C22H42N6
- The crystal structure of [N-{[2-(oxy)-4-methoxyphenyl](phenyl)methylidene}alaninato]-diphenyl-silicon(IV) – chloroform (1/1), C29H25NO4Si·CHCl3
- Crystal structure of tetracarbonyl-{μ-[N-(diphenylphosphanyl)-N,P,P-triphenylphosphinous amide]}-bis[μ-(phenylmethanethiolato)]diiron (Fe–Fe), C48H39Fe2NO4P2S2
- Crystal structure of baryte from Mine du Pradet (France)
- The crystal structure of [(2,2′-bipyridine-6-carboxylato-κ3 N,N,O)-(6-phenylpyridine-2-carboxylate-κ2 N,O)copper(II)] monohydrate, C23H17N3O5Cu
- Crystal structure of bis(μ-benzeneselenolato)-(μ-[N-benzyl-N-(diphenylphosphanyl)-P,P-diphenylphosphinous amide])-tetracarbonyl diiron (Fe–Fe), C47H37Fe2NO4P2Se2
- The crystal structure of diaqua-methanol-κ1 O- (3-thiophenecarboxylato-κO)-(2,2′-dipyridyl-κ2 N,N′)manganese(II) 3-thiophenecarboxylate, C21H22N2O7S2Mn
- Crystal structure of catena-poly[tetrakis(butyl)-μ2-2-((oxido(phenyl)methylene)hydrazineylidene)propanoato-κ4 O:O,O′,N-μ2-2-((oxido(phenyl)methylene)hydrazineylidene)propanoato-κ4 O,N,O′:N′-ditin(IV)], C34H50N6O6Sn2
- Crystal structure of 4-chloro-N′-[(1E)-(2-nitrophenyl)methylidene]benzohydrazide, C14H10ClN3O3
- The crystal structure of 3-(1′-deoxy-3′,5′-O-dibenzy-β-d-ribosyl)adenine dichloromethane solvate, C49H52Cl2N10O6
- The crystal structure of (Z)-4-amino-N′-(1-(o-tolyl)ethylidene)benzohydrazide, C16H17N3O
- The co-crystal structure of etoricoxib–phthalic acid (1/1), C18H15ClN2O2S·C8H6O4
- Crystal structure of (glycinto-κ 2 O,N ′)-[5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ 4 N,N ′,N ″,N ‴]nickel(II) perchlorate monohydrate C18H42ClN5NiO7
- The crystal structure of catena-poly[bis(1-ethylimidazole-k1 N)-(μ 2-benzene-1-carboxyl-3,5-dicarboxylato-κ 2 O, O′)zinc(II)], C19H20N4O6Zn
- Crystal structure of 3-(thiazol-2-ylcarbamoyl)-7-oxabicyclo[2.2.1]heptane-2-carboxylic acid, C11H12N2O4S
- Rietveld structure analysis of keatite, a rare, metastable SiO2 polymorph
- Crystal structure of catena-poly[(μ2-isophthalato-k3 O,O′:O″)(4-(4-pyridyl)-2,5-dipyrazylpyridine-k3 N,N′,N″)cobalt(II)] trihydrate C26H22N6O7Co1
- Crystal structure of 3,5–di-O-benzoyl-1,2-O-isopropylidene-α–D-ribose, C22H22O7
- The crystal structure of fac-tricarbonyl(6-bromo-2,2-bipyridine-κ2 N,N)-(nitrato-κO)rhenium(I), C13H7BrN3O6Re
- The crystal structure of (E)-N′-(4-hydroxy-3-methoxybenzylidene)-2-naphthohydrazide monohydrate, C19H18N2O4
- The crystal structure of 5,5′-diselanediyl-bis(2-hydroxybenzaldehyde), C14H10O4Se2
- The crystal structure of catena-poly[diaqua-m2-dicyanido-κ2 C:N-dicyanido-κ1 C-bis(4-(pyridin-4-yl)benzaldehyde-κ1N)iron(II)-platinum(II), C28H22N6O4PtFe
- Redetermination of the crystal structure of 5,14-dihydro-6,17-dimethyl-8,15-diphenyldibenzo(b,i)(1,4,8,11)tetra-azacyclotetradecine, C32H28N4
- Crystal structure of poly[(μ3-2-(3,5-dicarboxyphenyl) benzimidazole-6-carboxylato-κ4O:O:O′:O″)lead(II)] monohydrate, C16H10N2O7Pb
- The crystal structure of fac-tricarbonyl(2-pyridin-2-yl-quinoline-κ2 N,N′)-(pyrazole-κN)rhenium(I)nitrate, C20H14N4O3ReNO3
- Crystal structure of dibromo-dicarbonyl-bis(tricyclohexylphosphine)-osmium(II) dichloromethane solvate, C38H66Br2O2OsP2
- Crystal structure of poly[bis(μ 2-2,6-bis(1-imidazoly)pyridine-κ 2 N:N′)copper(II)] diperchlorate dihydrate, C22H22Cl2CuN10O10
- The crystal structure of fac-tricarbonyl(N-benzoyl-N,N-cyclohexylmethylcarbamimidothioato-κ2 S,O)-(pyridine-κN)rhenium(I), C23H24N3O4ReS
- Crystal structure of (E)-7-fluoro-2-(4-fluorobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C17H12F2O
- Synthesis and crystal structure of 1-((3R,10S,13S, 17S)-3-((2-methoxyphenyl)amino)-10,13-dimethylhexadecahydro-1H-cyclopenta[α]phenanthren-17-yl)ethan-1-one, C28H41NO2
- The crystal structure of fac-tricarbonyl((pyridin-2-yl)methanamino-κ2 N,N′)-((pyridin-2-yl)methanamino-κN)rhenium(I) nitrate, C15H16O3N4Re
- The crystal structure of (1-(pyridin-2-yl)-N-(pyridin-2-ylmethyl)-N-((1-(4-vinylbenzyl)-1H-benzo[d]imidazol-2-yl)methyl)methanamine-κ 4 N,N′,N″,N‴)tris(nitrato-kO,O′)-erbium(III), C29H27ErN8O9
- Crystal structure of tetracene-5,12-dione, C18H10O2
- Crystal structure of (3R,3aS,6R,6aR)-6-hexyl-3-methyltetrahydrofuro[3,4-b]furan-2,4-dione, C13H20O4
- The crystal structure of N′1,N′3-bis((E)-thiophen-2-ylmethylene)isophthalohydrazide monohydrate, C18H16N4O3S2
- Crystal structure of methyl ((4-aminobenzyl)sulfonyl)-L-prolinate, C13H18N2O4S
- Crystal structure of (E)-3-(3-methoxybenzylidene)benzofuran-2(3H)-one, C16H12O3
- Synthesis and crystal structure (E)-1-(4-bromo-2-hydroxyphenyl)-3-(dimethylamino)prop-2-en-1-one, C11H12BrNO2
- Synthesis and crystal structure of (S,E)-4-hydroxy-3-(2-((4aR,6aS,7R,10aS,10bR)-3,3,6a,10b-tetramethyl-8-methylenedecahydro-1H-naphtho[2,1-d][1,3]dioxin-7-yl)ethylidene)dihydrofuran-2(3H)-one, C23H34O5
- The crystal structure of N,N′-(1,2-phenylene)bis (2-((2-oxopropyl)selanyl)benzamide), C26H24N2O4Se2
- The crystal structure of 1-ethyl-2-nitro-imidazole oxide, C5H7N3O3
- The crystal structure of 2-(2-fluorophenyl)naphtho[2,1-d]thiazole, C17H10FNS
- Crystal structure of (E)-2,4-di-tert-butyl-6-(((2-fluorophenyl)imino) methyl)phenol, C21H26FNO
- Synthesis and crystal structure of 3-methyl-2-(methylthio)-4H-chromen-4-one, C12H12O2S
- Crystal structure of dithieno[2,3-d:2′,3′-d′]benzo[1,2-b:4,5-b′]dithiophene-5,10-dione, C14H4O2S4
- The crystal structure of dimethyl 2,2ʹ-((adamantane-1,3-diylbis(4,1-phenylene)) bis(oxy))diacetate, C28H32O6
- The crystal structure of N-(6-chloro-2-methyl-2H-indazol-5-yl)acetamide, C10H10ClN3O
- Crystal structure of triaqua-(5-bromoisophthalato-κ1 O)-(2,2′-bipyridine-κ2 N:N′)nickel(II) hydrate, C18H19BrN2NiO8
- The crystal structure of 2-amino-4-carboxypyridin-1-ium perchlorate, C6H7ClN2O6
- The crystal structure of catena-poly[5-aminonicotinic acid-k1 N-m2-bromido-copper(I)], Cu(C6N2H6O2)Br
- The crystal structure of 2,2-bis(3-methoxyphenyl)-1-tosyl-1,2-dihydro- 2λ4,3λ4 -[1,3,2]diazaborolo[4,5,1-ij]quinoline - dichloromethane (1/1)
- The crystal structure of catena-poly[bis(6-phenylpyridine-2-carboxylato-κ2 N,O)-(μ2-4,4′-bipyridne-κ2 N:N)cadmium(II)], C34H24N4O4Cd
- The crystal structure of 5,7-dinitropyrazolo[5,1-b]quinazolin-9(4H)-one, C10H5N5O5
- Crystal structure of rac-1,8-bis(2-carbamoylethyl)-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane, C22H46N6O2
- The crystal structure of (E)-N ′-(2-bromobenzylidene)-2-naphthohydrazide, C36H26Br2N4O2
- The crystal structure of 5-nitronaphthoquinone, C10H5NO4
- The crystal structure of (S, R p )-4–benzhydrylideneamino-12-(4-tert-butyl oxazolin-2-yl)[2.2]paracyclophane, C36H36N2O
- Synthesis and crystal structure of 2-(2-oxo-2-(o-tolyl)ethyl)-4H-chromen-4-one, C18H14O3
- Crystal structure of 2-(thiazol-2-yl)hexahydro-1H-4,7-epoxyisoindole-1,3(2H)-dione, C11H10N2O3S
- Crystal structure of N-(diaminomethylene)-1-(dimethylamino)-1-iminiomethanaminium dichloride, C4H13Cl2N5
- Crystal structure of poly[(μ3-3, 5-dichloro-2-hydroxy-benzoato-κ4 Cl,O:O′:O″) silver(I)], C7H3AgCl2O3
- The crystal structure of tetrakis(1-isopropylimidazole-κ1 N)-[μ2- imidazole-4,5-dicarboxylato-κ4 O,N,O′,N′)]- trioxido-divanadium, C29H41N10O7V2
- Crystal structure of catena-[(μ3-bromido)-(1H-1,2,4-triazol-1-yl)benzoato-κ1 N)copper(I)], C9H7BrCuN3O2
- The crystal structure of (E)-4-fluoro-N′-(1-(2-hydroxyphenyl)propylidene)benzohydrazide, C16H15FN2O2
Articles in the same Issue
- Frontmatter
- New Crystal Structures
- Crystal structure of a polymorph of potassium picrate, C6H2KN3O7
- The crystal structure of (1E,2E)-1,2-bis(quinolin-2-ylmethylene)hydrazine, C20H14N4
- 5-Amino-2-chloro-4-fluoro-N-(N-isopropyl-N-methylsulfamoyl) benzamide, C11H15O3ClFN3S
- Crystal structure of trans-N 1,N 8-bis(2-cyanoethyl)-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane, C22H42N6
- The crystal structure of [N-{[2-(oxy)-4-methoxyphenyl](phenyl)methylidene}alaninato]-diphenyl-silicon(IV) – chloroform (1/1), C29H25NO4Si·CHCl3
- Crystal structure of tetracarbonyl-{μ-[N-(diphenylphosphanyl)-N,P,P-triphenylphosphinous amide]}-bis[μ-(phenylmethanethiolato)]diiron (Fe–Fe), C48H39Fe2NO4P2S2
- Crystal structure of baryte from Mine du Pradet (France)
- The crystal structure of [(2,2′-bipyridine-6-carboxylato-κ3 N,N,O)-(6-phenylpyridine-2-carboxylate-κ2 N,O)copper(II)] monohydrate, C23H17N3O5Cu
- Crystal structure of bis(μ-benzeneselenolato)-(μ-[N-benzyl-N-(diphenylphosphanyl)-P,P-diphenylphosphinous amide])-tetracarbonyl diiron (Fe–Fe), C47H37Fe2NO4P2Se2
- The crystal structure of diaqua-methanol-κ1 O- (3-thiophenecarboxylato-κO)-(2,2′-dipyridyl-κ2 N,N′)manganese(II) 3-thiophenecarboxylate, C21H22N2O7S2Mn
- Crystal structure of catena-poly[tetrakis(butyl)-μ2-2-((oxido(phenyl)methylene)hydrazineylidene)propanoato-κ4 O:O,O′,N-μ2-2-((oxido(phenyl)methylene)hydrazineylidene)propanoato-κ4 O,N,O′:N′-ditin(IV)], C34H50N6O6Sn2
- Crystal structure of 4-chloro-N′-[(1E)-(2-nitrophenyl)methylidene]benzohydrazide, C14H10ClN3O3
- The crystal structure of 3-(1′-deoxy-3′,5′-O-dibenzy-β-d-ribosyl)adenine dichloromethane solvate, C49H52Cl2N10O6
- The crystal structure of (Z)-4-amino-N′-(1-(o-tolyl)ethylidene)benzohydrazide, C16H17N3O
- The co-crystal structure of etoricoxib–phthalic acid (1/1), C18H15ClN2O2S·C8H6O4
- Crystal structure of (glycinto-κ 2 O,N ′)-[5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ 4 N,N ′,N ″,N ‴]nickel(II) perchlorate monohydrate C18H42ClN5NiO7
- The crystal structure of catena-poly[bis(1-ethylimidazole-k1 N)-(μ 2-benzene-1-carboxyl-3,5-dicarboxylato-κ 2 O, O′)zinc(II)], C19H20N4O6Zn
- Crystal structure of 3-(thiazol-2-ylcarbamoyl)-7-oxabicyclo[2.2.1]heptane-2-carboxylic acid, C11H12N2O4S
- Rietveld structure analysis of keatite, a rare, metastable SiO2 polymorph
- Crystal structure of catena-poly[(μ2-isophthalato-k3 O,O′:O″)(4-(4-pyridyl)-2,5-dipyrazylpyridine-k3 N,N′,N″)cobalt(II)] trihydrate C26H22N6O7Co1
- Crystal structure of 3,5–di-O-benzoyl-1,2-O-isopropylidene-α–D-ribose, C22H22O7
- The crystal structure of fac-tricarbonyl(6-bromo-2,2-bipyridine-κ2 N,N)-(nitrato-κO)rhenium(I), C13H7BrN3O6Re
- The crystal structure of (E)-N′-(4-hydroxy-3-methoxybenzylidene)-2-naphthohydrazide monohydrate, C19H18N2O4
- The crystal structure of 5,5′-diselanediyl-bis(2-hydroxybenzaldehyde), C14H10O4Se2
- The crystal structure of catena-poly[diaqua-m2-dicyanido-κ2 C:N-dicyanido-κ1 C-bis(4-(pyridin-4-yl)benzaldehyde-κ1N)iron(II)-platinum(II), C28H22N6O4PtFe
- Redetermination of the crystal structure of 5,14-dihydro-6,17-dimethyl-8,15-diphenyldibenzo(b,i)(1,4,8,11)tetra-azacyclotetradecine, C32H28N4
- Crystal structure of poly[(μ3-2-(3,5-dicarboxyphenyl) benzimidazole-6-carboxylato-κ4O:O:O′:O″)lead(II)] monohydrate, C16H10N2O7Pb
- The crystal structure of fac-tricarbonyl(2-pyridin-2-yl-quinoline-κ2 N,N′)-(pyrazole-κN)rhenium(I)nitrate, C20H14N4O3ReNO3
- Crystal structure of dibromo-dicarbonyl-bis(tricyclohexylphosphine)-osmium(II) dichloromethane solvate, C38H66Br2O2OsP2
- Crystal structure of poly[bis(μ 2-2,6-bis(1-imidazoly)pyridine-κ 2 N:N′)copper(II)] diperchlorate dihydrate, C22H22Cl2CuN10O10
- The crystal structure of fac-tricarbonyl(N-benzoyl-N,N-cyclohexylmethylcarbamimidothioato-κ2 S,O)-(pyridine-κN)rhenium(I), C23H24N3O4ReS
- Crystal structure of (E)-7-fluoro-2-(4-fluorobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C17H12F2O
- Synthesis and crystal structure of 1-((3R,10S,13S, 17S)-3-((2-methoxyphenyl)amino)-10,13-dimethylhexadecahydro-1H-cyclopenta[α]phenanthren-17-yl)ethan-1-one, C28H41NO2
- The crystal structure of fac-tricarbonyl((pyridin-2-yl)methanamino-κ2 N,N′)-((pyridin-2-yl)methanamino-κN)rhenium(I) nitrate, C15H16O3N4Re
- The crystal structure of (1-(pyridin-2-yl)-N-(pyridin-2-ylmethyl)-N-((1-(4-vinylbenzyl)-1H-benzo[d]imidazol-2-yl)methyl)methanamine-κ 4 N,N′,N″,N‴)tris(nitrato-kO,O′)-erbium(III), C29H27ErN8O9
- Crystal structure of tetracene-5,12-dione, C18H10O2
- Crystal structure of (3R,3aS,6R,6aR)-6-hexyl-3-methyltetrahydrofuro[3,4-b]furan-2,4-dione, C13H20O4
- The crystal structure of N′1,N′3-bis((E)-thiophen-2-ylmethylene)isophthalohydrazide monohydrate, C18H16N4O3S2
- Crystal structure of methyl ((4-aminobenzyl)sulfonyl)-L-prolinate, C13H18N2O4S
- Crystal structure of (E)-3-(3-methoxybenzylidene)benzofuran-2(3H)-one, C16H12O3
- Synthesis and crystal structure (E)-1-(4-bromo-2-hydroxyphenyl)-3-(dimethylamino)prop-2-en-1-one, C11H12BrNO2
- Synthesis and crystal structure of (S,E)-4-hydroxy-3-(2-((4aR,6aS,7R,10aS,10bR)-3,3,6a,10b-tetramethyl-8-methylenedecahydro-1H-naphtho[2,1-d][1,3]dioxin-7-yl)ethylidene)dihydrofuran-2(3H)-one, C23H34O5
- The crystal structure of N,N′-(1,2-phenylene)bis (2-((2-oxopropyl)selanyl)benzamide), C26H24N2O4Se2
- The crystal structure of 1-ethyl-2-nitro-imidazole oxide, C5H7N3O3
- The crystal structure of 2-(2-fluorophenyl)naphtho[2,1-d]thiazole, C17H10FNS
- Crystal structure of (E)-2,4-di-tert-butyl-6-(((2-fluorophenyl)imino) methyl)phenol, C21H26FNO
- Synthesis and crystal structure of 3-methyl-2-(methylthio)-4H-chromen-4-one, C12H12O2S
- Crystal structure of dithieno[2,3-d:2′,3′-d′]benzo[1,2-b:4,5-b′]dithiophene-5,10-dione, C14H4O2S4
- The crystal structure of dimethyl 2,2ʹ-((adamantane-1,3-diylbis(4,1-phenylene)) bis(oxy))diacetate, C28H32O6
- The crystal structure of N-(6-chloro-2-methyl-2H-indazol-5-yl)acetamide, C10H10ClN3O
- Crystal structure of triaqua-(5-bromoisophthalato-κ1 O)-(2,2′-bipyridine-κ2 N:N′)nickel(II) hydrate, C18H19BrN2NiO8
- The crystal structure of 2-amino-4-carboxypyridin-1-ium perchlorate, C6H7ClN2O6
- The crystal structure of catena-poly[5-aminonicotinic acid-k1 N-m2-bromido-copper(I)], Cu(C6N2H6O2)Br
- The crystal structure of 2,2-bis(3-methoxyphenyl)-1-tosyl-1,2-dihydro- 2λ4,3λ4 -[1,3,2]diazaborolo[4,5,1-ij]quinoline - dichloromethane (1/1)
- The crystal structure of catena-poly[bis(6-phenylpyridine-2-carboxylato-κ2 N,O)-(μ2-4,4′-bipyridne-κ2 N:N)cadmium(II)], C34H24N4O4Cd
- The crystal structure of 5,7-dinitropyrazolo[5,1-b]quinazolin-9(4H)-one, C10H5N5O5
- Crystal structure of rac-1,8-bis(2-carbamoylethyl)-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane, C22H46N6O2
- The crystal structure of (E)-N ′-(2-bromobenzylidene)-2-naphthohydrazide, C36H26Br2N4O2
- The crystal structure of 5-nitronaphthoquinone, C10H5NO4
- The crystal structure of (S, R p )-4–benzhydrylideneamino-12-(4-tert-butyl oxazolin-2-yl)[2.2]paracyclophane, C36H36N2O
- Synthesis and crystal structure of 2-(2-oxo-2-(o-tolyl)ethyl)-4H-chromen-4-one, C18H14O3
- Crystal structure of 2-(thiazol-2-yl)hexahydro-1H-4,7-epoxyisoindole-1,3(2H)-dione, C11H10N2O3S
- Crystal structure of N-(diaminomethylene)-1-(dimethylamino)-1-iminiomethanaminium dichloride, C4H13Cl2N5
- Crystal structure of poly[(μ3-3, 5-dichloro-2-hydroxy-benzoato-κ4 Cl,O:O′:O″) silver(I)], C7H3AgCl2O3
- The crystal structure of tetrakis(1-isopropylimidazole-κ1 N)-[μ2- imidazole-4,5-dicarboxylato-κ4 O,N,O′,N′)]- trioxido-divanadium, C29H41N10O7V2
- Crystal structure of catena-[(μ3-bromido)-(1H-1,2,4-triazol-1-yl)benzoato-κ1 N)copper(I)], C9H7BrCuN3O2
- The crystal structure of (E)-4-fluoro-N′-(1-(2-hydroxyphenyl)propylidene)benzohydrazide, C16H15FN2O2